Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 2
1966 2
1967 1
1968 3
1970 1
1971 3
1973 3
1975 1
1976 4
1977 1
1978 1
1979 1
1980 2
1981 5
1982 2
1983 1
1984 7
1985 3
1986 6
1987 1
1988 3
1989 6
1990 4
1991 8
1992 5
1993 3
1994 2
1995 4
1996 4
1997 1
1998 7
1999 9
2000 5
2001 5
2002 4
2003 5
2004 1
2005 4
2006 4
2007 1
2009 1
2010 5
2011 3
2012 3
2013 2
2014 9
2015 5
2016 7
2017 7
2018 8
2019 4
2020 13
2021 14
2022 12
2023 14
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Results by year

Filters applied: . Clear all
Page 1
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.
Singh K, Hotchkiss KM, Parney IF, De Groot J, Sahebjam S, Sanai N, Platten M, Galanis E, Lim M, Wen PY, Minniti G, Colman H, Cloughesy TF, Mehta MP, Geurts M, Arrillaga-Romany I, Desjardins A, Tanner K, Short S, Arons D, Duke E, Wick W, Bagley SJ, Ashley DM, Kumthekar P, Verhaak R, Chalmers AJ, Patel AP, Watts C, Fecci PE, Batchelor TT, Weller M, Vogelbaum MA, Preusser M, Berger MS, Khasraw M. Singh K, et al. Among authors: duke e. Nat Med. 2023 Oct;29(10):2402-2405. doi: 10.1038/s41591-023-02464-8. Nat Med. 2023. PMID: 37488293 No abstract available.
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.
Duke ES, Bradford D, Marcovitz M, Amatya AK, Mishra-Kalyani PS, Nguyen E, Price LSL, Fourie Zirkelbach J, Li Y, Bi Y, Kraft J, Dorff SE, Scepura B, Stephenson M, Ojofeitimi I, Nair A, Han Y, Tezak Z, Lemery SJ, Pazdur R, Larkins E, Singh H. Duke ES, et al. Clin Cancer Res. 2023 Sep 15;29(18):3573-3578. doi: 10.1158/1078-0432.CCR-23-0459. Clin Cancer Res. 2023. PMID: 37265412 Free PMC article. Clinical Trial.
Cancer Prevalence Across Vertebrates.
Compton ZT, Harris V, Mellon W, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez L, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Zehnder A, Graham TA, Troan B, Harrison TM, Tollis M, Schiffman JD, Aktipis A, Abegglen LM, Maley CC, Boddy AM. Compton ZT, et al. Among authors: duke eg. Res Sq [Preprint]. 2023 Jul 6:rs.3.rs-3117313. doi: 10.21203/rs.3.rs-3117313/v1. Res Sq. 2023. PMID: 37461608 Free PMC article. Preprint.
Cancer Prevalence Across Vertebrates.
Compton Z, Harris V, Mellon W, Rupp S, Mallo D, Kapsetaki SE, Wilmot M, Kennington R, Noble K, Baciu C, Ramirez L, Peraza A, Martins B, Sudhakar S, Aksoy S, Furukawa G, Vincze O, Giraudeau M, Duke EG, Spiro S, Flach E, Davidson H, Zehnder A, Graham TA, Troan B, Harrison TM, Tollis M, Schiffman JD, Aktipis A, Abegglen LM, Maley CC, Boddy AM. Compton Z, et al. Among authors: duke eg. bioRxiv [Preprint]. 2023 Feb 16:2023.02.15.527881. doi: 10.1101/2023.02.15.527881. bioRxiv. 2023. PMID: 36824942 Free PMC article. Preprint.
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.
Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugières L, Jones DTW, Pajtler KW, Morrissy AS, Kool M, Sturm D, Chavez L, Ernst A, Brabetz S, Hain M, Zichner T, Segura-Wang M, Weischenfeldt J, Rausch T, Mardin BR, Zhou X, Baciu C, Lawerenz C, Chan JA, Varlet P, Guerrini-Rousseau L, Fults DW, Grajkowska W, Hauser P, Jabado N, Ra YS, Zitterbart K, Shringarpure SS, De La Vega FM, Bustamante CD, Ng HK, Perry A, MacDonald TJ, Hernáiz Driever P, Bendel AE, Bowers DC, McCowage G, Chintagumpala MM, Cohn R, Hassall T, Fleischhack G, Eggen T, Wesenberg F, Feychting M, Lannering B, Schüz J, Johansen C, Andersen TV, Röösli M, Kuehni CE, Grotzer M, Kjaerheim K, Monoranu CM, Archer TC, Duke E, Pomeroy SL, Shelagh R, Frank S, Sumerauer D, Scheurlen W, Ryzhova MV, Milde T, Kratz CP, Samuel D, Zhang J, Solomon DA, Marra M, Eils R, Bartram CR, von Hoff K, Rutkowski S, Ramaswamy V, Gilbertson RJ, Korshunov A, Taylor MD, Lichter P, Malkin D, Gajjar A, Korbel JO, Pfister SM. Waszak SM, et al. Among authors: duke e. Lancet Oncol. 2018 Jun;19(6):785-798. doi: 10.1016/S1470-2045(18)30242-0. Epub 2018 May 9. Lancet Oncol. 2018. PMID: 29753700 Free PMC article.
Neuro-Oncology Training for the Child Neurology Resident.
Malbari F, Partap S, Gust J, Duke E, Sato A, Khakoo Y, Ullrich NJ. Malbari F, et al. Among authors: duke e. J Child Neurol. 2021 Jan;36(1):79-82. doi: 10.1177/0883073820955101. Epub 2020 Sep 9. J Child Neurol. 2021. PMID: 32907446 Free PMC article. Review.
Idiopathic CD4 Lymphocytopenia at 30 Years.
Striker R, Siraj DS, Duke ER. Striker R, et al. Among authors: duke er. N Engl J Med. 2023 Aug 17;389(7):674-675. doi: 10.1056/NEJMc2307362. N Engl J Med. 2023. PMID: 37585646 No abstract available.
233 results